World's Best Scientists 2026 revealed!
Peter Verhamme

Peter Verhamme

D-Index & Metrics

Medicine

D-Index
80
Citations
47455
World Ranking
16865
National Ranking
210

Overview

Peter Verhamme is affiliated with KU Leuven in Belgium and has a research focus primarily in the field of Medicine. Their work spans several subfields, including Cardiology and Cardiovascular Medicine, Internal Medicine, Infectious Diseases, Surgery, and Hematology.

The main topics addressed in their research include:

  • Venous Thromboembolism Diagnosis and Management
  • Atrial Fibrillation Management and Outcomes
  • COVID-19 Clinical Research Studies
  • Blood Coagulation and Thrombosis Mechanisms
  • Antiplatelet Therapy and Cardiovascular Diseases
  • Blood Pressure and Hypertension Studies
  • Acute Ischemic Stroke Management

Verhamme has published extensively, with frequent contributions to several key journals such as:

  • Journal of Hypertension
  • European Heart Journal
  • Journal of Thrombosis and Haemostasis
  • Research and Practice in Thrombosis and Haemostasis
  • Thrombosis Research

Frequently collaborating with other researchers, common coauthors include:

  • Thomas Vanassche
  • Jan A. Staessen
  • Jesús D. Melgarejo
  • Zhen-Yu Zhang
  • Stefan Janssens

Selected recent papers by Peter Verhamme include:

  • Abelacimab for Prevention of Venous Thromboembolism, 2021, New England Journal of Medicine
  • American Society of Hematology 2020 Guidelines for Management of Venous Thromboembolism: Treatment of Deep Vein Thrombosis and Pulmonary Embolism, 2020, Blood Advances
  • Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study, 2022, The Lancet
  • Andexanet for Factor Xa Inhibitor-Associated Acute Intracerebral Hemorrhage, 2024, New England Journal of Medicine
  • Role of Combination Antiplatelet and Anticoagulation Therapy in Diabetes Mellitus and Cardiovascular Disease, 2020, Circulation

Best Publications

  • Oral rivaroxaban for symptomatic venous thromboembolism

    Rupert Bauersachs;Scott D. Berkowitz;Benjamin Brenner;Harry R. Buller

  • Oral Rivaroxaban for the Treatment of Symptomatic Pulmonary Embolism

    Barry F. Jacobson;Erich Minar;Jaromir Chlumsky;Peter Verhamme

  • Edoxaban versus Warfarin for the Treatment of Symptomatic Venous Thromboembolism

    Harry R. Büller;Hervé Décousus;Michael A. Grosso;Saskia Middeldorp

  • Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease

    John W. Eikelboom;Stuart J. Connolly;Jackie Bosch;Gilles R. Dagenais

  • The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation.

    Steffel J;Verhamme P;Potpara Ts;Albaladejo P

  • Idarucizumab for Dabigatran Reversal

    Charles V. Pollack;Paul A. Reilly;John Eikelboom;Stephan Glund

  • Updated European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillation.

    Hein Heidbuchel;Peter Verhamme;Marco Alings;Matthias Antz

  • Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism

    Gary E. Raskob;Nick van Es;Peter Verhamme;Marc Carrier

  • European Heart Rhythm Association Practical Guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation

    Hein Heidbuchel;Peter Verhamme;Marco Alings;Matthias Antz

  • Idarucizumab for Dabigatran Reversal — Full Cohort Analysis

    Charles V. Pollack;Paul A. Reilly;Joanne van Ryn;John W. Eikelboom

  • American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism.

    Thomas L. Ortel;Ignacio Neumann;Walter Ageno;Rebecca Beyth;Rebecca Beyth

  • Andexanet Alfa for Acute Major Bleeding Associated with Factor Xa Inhibitors

    Stuart J. Connolly;Truman J. Milling;John W. Eikelboom;C. Michael Gibson

  • Full Study Report of Andexanet Alfa for Bleeding Associated with Factor Xa Inhibitors

    Stuart J. Connolly;Mark Crowther;John W. Eikelboom;C. Michael Gibson

  • Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism

    Jeffrey I. Weitz;Anthonie W.A. Lensing;Martin H. Prins;Rupert Bauersachs

  • Circulating Oxidized LDL Is a Useful Marker for Identifying Patients With Coronary Artery Disease

    Paul Holvoet;Ann Mertens;Peter Verhamme;Kris Bogaerts

  • Outpatient versus inpatient treatment for patients with acute pulmonary embolism : an international, open-label, randomised, non-inferiority trial.

    Drahomir Aujesky;Pierre-Marie Roy;Franck Verschuren;Marc Philip Righini

  • Factor XI Antisense Oligonucleotide for Prevention of Venous Thrombosis

    Harry Roger Buller;Claudette Bethune;Sanjay Bhanot;David Gailani

  • EHRA Practical Guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation : executive summary

    Hein Heidbuchel;Peter Verhamme;Marco Alings;Matthias Antz

  • Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism

    G.E. Raskob;N. van Es;P. Verhamme;M. Carrier

  • European Heart Rhythm Association Practical G u i d eo nt h e u s eo fn e w o r a l a n t i c o a g u l a n t s i n patients with non-valvular atrial fibrillation

    Hein Heidbuchel;Peter Verhamme;Marco Alings;Matthias Antz

Frequent Co-Authors

Walter Ageno
Walter Ageno University of Insubria
John W. Eikelboom
John W. Eikelboom Population Health Research Institute
Jeffrey I. Weitz
Jeffrey I. Weitz McMaster University
Paolo Prandoni
Paolo Prandoni University of Padua
Manuel Monreal
Manuel Monreal Autonomous University of Barcelona
Gary E. Raskob
Gary E. Raskob University of Oklahoma Health Sciences Center
Saskia Middeldorp
Saskia Middeldorp Radboud University Medical Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring alternative healthcare degrees online can open up new career pathways for those interested in the medical field. Many students who consider medical school also look into fast track medical programs, such as Licensed Practical Nurse (LPN) courses. These programs offer a quicker entry into patient care roles and provide valuable experience.

For those with a passion for mental health, becoming a Psychiatric Nurse Practitioner is another rewarding route. Accredited schools now provide flexible and accessible options like the psych np programs online, allowing professionals to advance their qualifications while working.

If you prefer the administrative side of healthcare, earning a Master’s in Healthcare Administration (MHA) could be the right fit. Many universities offer the cheapest mha programs online, helping students gain vital management skills without overwhelming debt. Researching cheap mha programs can help you find high-quality options that suit your budget and career goals.

Best Scientists Citing Peter Verhamme

Trending Scientists